NCT05429684 2022-06-23
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 3 Unknown
First Affiliated Hospital Xi'an Jiaotong University
Huazhong University of Science and Technology
Fudan University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Zhejiang Cancer Hospital
Fudan University